Related Experiment Video
Updated: Apr 27, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study
Gilles Macaigne1, Pierre Lahmek2, Christophe Locher3
1Service de Gastro-Entérologie, Centre Hospitalier de Marne la Vallée, Jossigny, France.
Microscopic colitis (MC) is more likely in patients over 50 with nocturnal stools, weight loss, recent drug changes, or autoimmune disease. These factors indicate a need for colonoscopy with biopsies to diagnose MC.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pathology
Background:
- Microscopic colitis (MC), encompassing lymphocytic colitis (LC) and collagenous colitis (CC), is a condition causing chronic diarrhea.
- Differentiating MC from functional bowel disorder with diarrhea (FBD-D) is crucial for appropriate patient management.
- Identifying specific predictors for MC can aid in early diagnosis and intervention.
Purpose of the Study:
- To characterize a cohort of patients diagnosed with microscopic colitis (MC).
- To compare the demographic, clinical, biological, and etiological features of MC patients with those of functional bowel disorder with diarrhea (FBD-D) patients.
- To identify predictors that increase the likelihood of microscopic colitis.
Main Methods:
- A prospective cohort study was conducted across 26 centers in France between September 2010 and June 2012.
- Patients with at least three daily bowel movements for over four weeks and normal colonoscopy were included.
- Demographic, clinical, biological, and etiological data were collected and compared between MC and FBD-D groups using logistic regression analysis.
Main Results:
- The study included 433 patients: 129 with MC (87 LC, 42 CC) and 278 with FBD-D.
- Independent predictors for MC included age over 50 (OR=3.1), nocturnal stools (OR=2), weight loss (OR=2.5), diarrhea duration under 12 months (OR=2.0), recent drug introduction (OR=3.7), and autoimmune disorders (OR=5.5).
Conclusions:
- Age over 50, nocturnal stools, weight loss, recent drug initiation, and a history of autoimmune disease are significant indicators for microscopic colitis.
- These findings highlight the importance of considering these factors when evaluating patients with chronic diarrhea.
- The presence of these predictors warrants a colonoscopy with biopsies for definitive diagnosis of MC.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Ulcerative Colitis
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

